Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-586P (U6 small nuclear RNA 586, pseudogene) is a non-coding RNA pseudogene corresponding to the U6 small nuclear RNA (snRNA) family. U6 snRNA is highly conserved and a key component of the major spliceosome, participating in the excision of introns from pre-mRNA—a central step in eukaryotic gene expression[1][3][4][5]. In contrast, RNU6-586P itself is classified as a pseudogene: it is a non-functional genomic locus related to the U6 snRNA gene, typically generated via duplication or retrotransposition events, and generally bearing disabling mutations or structural rearrangements that prevent the production of a functional RNA[4][7][2]. U6 snRNA pseudogenes such as RNU6-586P play no known direct biological or disease-related roles, do not encode functional products, and are not considered therapeutic targets, biomarkers, or drug interaction partners[2][4][7]. Their presence reflects genomic evolutionary processes rather than active cellular functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 586, pseudogene (RNU6-586P).